Gastroenterology
1 drug is in development for Hepatitis B.
- Companies
- 1
- Clinical trials
- 15
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Hepatitis B pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| vbi-2601 | VBI VACCINES INC/BC (VBIV) |
About this indication
Hepatitis B context
Gastroenterology·MeSH: Hepatitis B (D006509)
Also known as: Hepatitis B Virus Infection
Prevalence
900.0 / 100K
Incidence
10.0 / 100K/yr
Frequently asked questions
How many drugs are in development for Hepatitis B?
BioSniper tracks 1 drug in development for Hepatitis B across 1 company.
How many clinical trials target Hepatitis B?
There are 15 clinical trials targeting Hepatitis B tracked by BioSniper.
What is the prevalence of Hepatitis B?
The estimated prevalence of Hepatitis B is approximately 900.0 per 100,000 population.